Pregnant People-Infant Linked Longitudinal Surveillance

The summary for the Pregnant People-Infant Linked Longitudinal Surveillance grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control NCBDDD, which is the U.S. government agency offering this grant.

Pregnant People-Infant Linked Longitudinal Surveillance: CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD23-2303, Mother-Infant Linked Longitudinal Surveillance. The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 1, 2023. The purpose of this NOFO is to conduct mother-infant linked longitudinal surveillance on key exposures and outcomes of public health interest through both a clinic- and health department-based approach. These approaches collect health information from various sources and/or conduct data linkages, resulting in robust data across multiple years from pregnancy into childhood. The cooperative agreement intends to sustain, improve, and expand surveillance efforts from clinical sites and health departments related to mother-infant linked longitudinal data to ensure timely reporting of key exposures and outcomes that impact pregnant people and infants, to improve data quality and share evolving outcome data, to innovate clinical strategies, and build a strong collaborative network. Priority exposures and outcomes of public health interest may include, but not limited to medication for opioid use disorder, neonatal abstinence syndrome, cytomegalovirus, stillbirths (not intended to be longitudinal), and other conditions that may have serious impacts on pregnant people and infants. Strategic areas of focus may include advancing interoperability, data quality and informatics, and innovating and strengthening public health reporting. Focus areas may also include monitoring maternal, infant, and child outcomes including follow-up for diverse clinical and neurodevelopmental outcomes of children exposed to infectious and non-infectious threats that are not currently national notifiable.

Federal Grant Title:	Pregnant People-Infant Linked Longitudinal Surveillance
Federal Agency Name:	Centers for Disease Control NCBDDD (HHS-CDC-NCBDDD)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	CDC-RFA-DD-23-0003
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.073
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 10th, 2023
Original Application Deadline:	April 10th, 2023
Posted Date:	February 9th, 2023
Creation Date:	February 9th, 2023
Archive Date:	May 10th, 2023
Total Program Funding:	$5,000,000
Maximum Federal Grant Award:	$0
Minimum Federal Grant Award:	$0
Expected Number of Awards:	22
Cost Sharing or Matching:	No
Last Updated:	February 9th, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Eligible applicants must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic or population-based surveillance. This authority allows unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. This may be an MOU, letter of support, or other legal documentation to demonstrate public health authority, legislative mandate, or legal access to the data. Eligible applicants must document this authority in "Other Attachment Forms" with attachment name "Legal Authority" as a PDF uploaded to www.grants.gov. CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a Bona Fide Agent of a state government, a letter from the state government as documentation of the status is required and should be submitted under "Other Attachment Forms" with attachment name "Bona Fide Agent.” If the Bona Fide Agent attachment does not specify legal authority, the applicant must include an attachment named "Legal Authority" in "Other Attachment Forms". The NOFO has three components: A, B, and C. Eligible applicants may only apply for Component A, Component B, or Component C. If an applicant submits multiple applications, all applications will be deemed non-responsive, and none will receive further review. In the “Descriptive Title of Applicant's Project” on the SF-424 form, applicants must identify the component to which they are applying.
Grant Announcement Contact: Pregnant People-Infant Linked Longitudinal Surveillance Team
[email protected]
[email protected]
Similar Government Grants: • Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults; • Surveillance of Muscular Dystrophies; • Surveillance of Spina Bifida across the Lifespan; • Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity ...; • Documenting outcomes associated with Persistent Tic Disorders (including Tourette Syndrome...; • Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Incom...; • Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers; • Utilizing Existing Birth Defects Surveillance Programs to Include Surveillance Data on Sti...
More Grants from the Centers for Disease Control NCBDDD: • Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults; • Surveillance of Muscular Dystrophies; • Surveillance of Spina Bifida across the Lifespan